Literature DB >> 16649211

Genetic overlap between P300, P50, and duration mismatch negativity.

Mei Hua Hall1, Katja Schulze, Elvira Bramon, Robin M Murray, Pak Sham, Frühling Rijsdijk.   

Abstract

Mismatch Negativity (MMN), P300, and P50 suppression event-related potential (ERP) components measure intermediate stages of information processing but little is known of how they relate to each other genetically. The present study used multivariate genetic model fitting analytic techniques in 46 monozygotic and 32 dizygotic twin pairs. P300, P50 suppression, and MMN were recorded using a 19-channel electroencephalograph (EEG). Zygosity was determined using DNA genotyping. Little evidence for either genetic or environmental association between each of the three ERP paradigms was found. This result suggests that P300, MMN, and P50 suppression serve to evaluate different brain information processing functions that may be mediated by distinct neurobiological mechanisms which in turn are influenced by different sets of genes. Within paradigm, P300 amplitude and latency shared about half of their genetic effects.

Entities:  

Mesh:

Year:  2006        PMID: 16649211     DOI: 10.1002/ajmg.b.30318

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  20 in total

1.  The genetic and environmental influences of event-related gamma oscillations on bipolar disorder.

Authors:  Mei-Hua Hall; Kevin M Spencer; Katja Schulze; Colm McDonald; Sridevi Kalidindi; Eugenia Kravariti; Fergus Kane; Robin M Murray; Elvira Bramon; Pak Sham; Frühling Rijsdijk
Journal:  Bipolar Disord       Date:  2011-05       Impact factor: 6.744

Review 2.  Genetic psychophysiology: advances, problems, and future directions.

Authors:  Andrey P Anokhin
Journal:  Int J Psychophysiol       Date:  2014-04-13       Impact factor: 2.997

3.  Neurophysiologic effect of GWAS derived schizophrenia and bipolar risk variants.

Authors:  Mei-Hua Hall; Deborah L Levy; Dean F Salisbury; Steve Haddad; Patience Gallagher; Mary Lohan; Bruce Cohen; Dost Ongür; Jordan W Smoller
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-11-08       Impact factor: 3.568

4.  Cholinergic modulation of auditory processing, sensory gating and novelty detection in human participants.

Authors:  Inge Klinkenberg; Arjan Blokland; Wim J Riedel; Anke Sambeth
Journal:  Psychopharmacology (Berl)       Date:  2012-10-03       Impact factor: 4.530

5.  Thought Disorder in Schizophrenia and Bipolar Disorder Probands, Their Relatives, and Nonpsychiatric Controls.

Authors:  Charity J Morgan; Michael J Coleman; Ayse Ulgen; Lenore Boling; Jonathan O Cole; Frederick V Johnson; Jan Lerbinger; J Alexander Bodkin; Philip S Holzman; Deborah L Levy
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

6.  Familial Influences on Mismatch Negativity and Its Association with Plasma Glutamate Level: A Magnetoencephalographic Study in Twins.

Authors:  Yukika Nishimura; Yuki Kawakubo; Motomu Suga; Kenji Hashimoto; Yuichi Takei; Kunio Takei; Hideyuki Inoue; Masato Yumoto; Ryu Takizawa; Kiyoto Kasai
Journal:  Mol Neuropsychiatry       Date:  2016-09-20

7.  Profile of auditory information-processing deficits in schizophrenia.

Authors:  Bruce I Turetsky; Warren B Bilker; Steven J Siegel; Christian G Kohler; Raquel E Gur
Journal:  Psychiatry Res       Date:  2008-11-06       Impact factor: 3.222

8.  Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem.

Authors:  Dwight Dickinson; Philip D Harvey
Journal:  Schizophr Bull       Date:  2008-08-09       Impact factor: 9.306

Review 9.  Neurophysiological biomarkers for drug development in schizophrenia.

Authors:  Daniel C Javitt; Kevin M Spencer; Gunvant K Thaker; Georg Winterer; Mihály Hajós
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

10.  A new role for endophenotypes in the GWAS era: functional characterization of risk variants.

Authors:  Mei-Hua Hall; Jordan W Smoller
Journal:  Harv Rev Psychiatry       Date:  2010 Jan-Feb       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.